SMAD3 and non-small cell lung carcinoma: Nobiletin and Epicatechin-3-gallate can inhibit epithelial-mesenchymal transition of human non-small cell lung cancer cells by antagonizing the TGF-beta1/Smad3 signaling pathway [29, 30].